Skip to main content
Log in

How to publish with us

Publishing options

Archivum Immunologiae et Therapiae Experimentalis is a hybrid open access journal. Once the article is accepted for publication, authors will have the option to choose how their article is published:

  1. Traditional publishing model – published articles are made available to institutions and individuals who subscribe to Archivum Immunologiae et Therapiae Experimentalis or who pay to read specific articles.
  2. Open Access – when an article is accepted for publication, the author/s or funder/s pay an Article Processing Charge (APC). The final version of the published article is then free to read for everyone.

Authors may need to take specific actions to achieve compliance with funder and institutional open access mandates. If your research is supported by a funder that requires immediate open access (e.g. according to Plan S principles) then you should select the gold OA route, and we will direct you to the compliant route where possible. For authors selecting the subscription publication route, the journal's standard licensing terms will need to be accepted, including self-archiving policies. Those licensing terms will supersede any other terms that the author or any third party may assert apply to any version of the manuscript.

Benefits of open access

Publishing open access offers a number of benefits, including greater reach and readership for your work:

  • Cited more

    1.6x more citations of OA articles than non-OA articles across all subjects

  • Downloaded more

    4x more downloads of OA articles than non-OA articles

  • Greater impact

    2.5x more Altmetric attention. OA articles attracted 1.9x more news mentions and 1.2x more policy mentions

Find out more about benefits of open access.

Publication fees

For information about any relevant fees for publishing in Archivum Immunologiae et Therapiae Experimentalis, please check the journal homepage or contact the Open Research Support team (

Visit our open access support portal for further information.

Creative Commons licences

Open access articles in Springer Nature journals are published under Creative Commons licences. These provide an industry-standard framework to support easy re-use of open access material. Under Creative Commons licences, authors retain copyright of their articles.

Archivum Immunologiae et Therapiae Experimentalis articles are published open access under a CC BY licence (Creative Commons Attribution 4.0 International licence). The CC BY licence is the most open licence available and considered the industry 'gold standard' for open access; it is also preferred by many funders. This licence allows readers to copy and redistribute the material in any medium or format, and to alter, transform, or build upon the material, including for commercial use, providing the original author is credited.

In instances where authors are not allowed to retain copyright to their own article (where the author is a US Government employee for example), authors should contact the Open Research Support team ( before submitting their article so we can advise as to whether their non-standard copyright request can be accommodated.

Authors are advised to check their funder's requirements before selecting open access, to ensure compliance. Learn more about funder compliance.